Webinar: When platforms evolve - managing device change in a platformed world

Platform approaches have become a well-established strategy in drug delivery, valued for the efficiency, consistency, and scalability they can provide throughout the lifecycle of drug-device combination products. Today, pharmaceutical companies are increasingly seeking to leverage a single device platform across multiple products and biosimilars to accelerate development while reducing risk.

On June 22, SHL Medical, together with Kymanox, will host a webinar titled “When Platforms Evolve – Managing Device Change in a Platformed World.” During the session, Dr. Nina Fetz, Customer Solutions Senior Manager at SHL Medical, and Katy Rommel, PhD, Senior Director of Product Development and Commercialization at Kymanox will explore practical strategies for managing platform evolution and the associated regulatory considerations for drug-device combination products.

The webinar will cover:

• Understanding the opportunities and challenges associated with leveraging platform device strategies across multiple products and biosimilars. 
• Learning how to evaluate the regulatory and user impact of post-commercialization device changes, particularly those affecting Essential Drug Delivery Outputs (EDDOs) and user interfaces.
• Exploring practical approaches for bridging studies, governance controls, and risk management to help maintain platform consistency while supporting long-term product and portfolio success.